Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00726_DB00951_nanopub.RAzgmMyFQUTiuWLj0pxVRA7grCRcV8RCv7GQmlH3p47-U#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00726_DB00951 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00726_DB00951 label "DDI between Trimipramine and Isoniazid - The strong CYP3A4/CYP2C19 inhibitor, Isoniazide, may decrease the metabolism and clearance of Trimipramine, a CYP3A4/CYP2C19 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimipramine if Isoniazid is initiated, discontinued or dose changed. [drugbank_resource:DB00726_DB00951]" assertion.
- drugbank_resource:DB00726_DB00951 identifier "drugbank_resource:DB00726_DB00951" assertion.
- drugbank_resource:DB00726_DB00951 title "DDI between Trimipramine and Isoniazid - The strong CYP3A4/CYP2C19 inhibitor, Isoniazide, may decrease the metabolism and clearance of Trimipramine, a CYP3A4/CYP2C19 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimipramine if Isoniazid is initiated, discontinued or dose changed." assertion.
- drugbank:DB00726 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00726_DB00951 assertion.
- drugbank:DB00951 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00726_DB00951 assertion.